www.summitMD.com

Biomarker

Associations of inflammatory markers with coronary artery calcification: results from the Multi-Ethnic Study of Atherosclerosis
Atherosclerosis, 2010. 209(1): p. 226-9.
N. S. Jenny, et al.,

Cholesteryl ester transfer protein and mortality in patients undergoing coronary angiography: the Ludwigshafen Risk and Cardiovascular Health study
Circulation, 2010. 121(3): p. 366-74.
A. Ritsch, et al.,

Circulating microRNA: a novel potential biomarker for early diagnosis of acute myocardial infarction in humans
Eur Heart J, 2010. 31(6): p. 659-66.
G. K. Wang, et al.,

Comparison of usefulness of heart-type fatty acid binding protein versus cardiac troponin T for diagnosis of acute myocardial infarction
Am J Cardiol, 2010. 105(1): p. 1-9.
G. Haltern, et al.,

Early C-reactive protein in the prediction of long-term outcomes after acute coronary syndromes: a meta-analysis of longitudinal studies
Heart, 2010. 96(5): p. 339-46.
L. P. He, et al.,

Elevated CK-MB values after routine angioplasty predicts worse long-term prognosis in low-risk patients
Scand Cardiovasc J, 2010. 44(2): p. 69-75.
K. Vikenes, et al.,

Noninvasive assessment of left ventricular filling pressure after acute myocardial infarction: a prospective study of the relative prognostic utility of clinical assessment, echocardiography, and B-type natriuretic peptide
Am Heart J, 2010. 159(1): p. 47-54.
K. Kruszewski, et al.,

Plasma N-terminal fragment of the prohormone B-type natriuretic peptide concentrations in relation to time to treatment and Thrombolysis in Myocardial Infarction (TIMI) flow: a substudy of the Assessment of the Safety and Efficacy of a New Treatment Strategy with Percutaneous Coronary Intervention (ASSENT IV-PCI) trial
Am Heart J, 2010. 159(1): p. 131-40.
R. Jarai, et al.,

Soluble urokinase-type plasminogen activator receptor forms in plasma as markers of atherosclerotic plaque vulnerability
Clin Biochem, 2010. 43(1-2): p. 124-30.
F. J. Olson, et al.,

Prevalence and prognostic significance of incidental cardiac troponin T elevation in ambulatory patients with stable coronary artery disease: data from the Heart and Soul study
Am Heart J, 2009. 158(4): p. 673-9.
B. P. Hsieh, et al.,

Prognostic value of B-type natriuretic peptide for cardiovascular events independent of left ventricular end-diastolic pressure
Am Heart J, 2009. 158(5): p. 777-83.
R. K. Rogers, et al.,

Usefulness of combining serum uric acid and C-reactive protein for risk stratification of patients with coronary artery disease (Bezafibrate Infarction Prevention [BIP] study)
Am J Cardiol, 2009. 104(2): p. 194-8.
Y. Brodov, et al.,

Prognostic significance of small troponin I rise after a successful elective percutaneous coronary intervention of a native artery
Am J Cardiol, 2009. 103(5): p. 639-45.
A. De Labriolle, et al.,

Relation of clinical benefit of raising high-density lipoprotein cholesterol to serum levels of low-density lipoprotein cholesterol in patients with coronary heart disease (from the Bezafibrate Infarction Prevention Trial)
Am J Cardiol, 2009. 103(1): p. 41-5.
I. Goldenberg, et al.,

Usefulness of pregnancy-associated plasma protein A in patients with acute coronary syndrome
Am J Cardiol, 2009. 104(11): p. 1465-71.
K. K. Iversen, et al.,

Usefulness of elevations in serum choline and free F2)-isoprostane to predict 30-day cardiovascular outcomes in patients with acute coronary syndrome
Am J Cardiol, 2009. 104(5): p. 638-43.
R. M. LeLeiko, et al.,

Comparison of site-reported and core laboratory-reported creatine kinase-MB values in non-ST-segment elevation acute coronary syndrome (from the international trial SYNERGY)
Am J Cardiol, 2009. 104(10): p. 1330-5.
J. P. Linefsky, et al.,

Usefulness of serum cathepsin L as an independent biomarker in patients with coronary heart disease
Am J Cardiol, 2009. 103(4): p. 476-81.
Y. Liu, et al.,

Relation of kidney function and albuminuria with atrial fibrillation (from the Heart and Soul Study)
Am J Cardiol, 2009. 104(11): p. 1551-5.
D. D. McManus, et al.,

Plasma N-terminal prohormone brain natriuretic peptide as a marker for postoperative cardiac events in high-risk patients undergoing noncardiac surgery
Am J Cardiol, 2009. 104(1): p. 137-40.
R. C. Schutt, C. Cevik and M. P. Phy,

Prognostic accuracy of B-natriuretic peptide measurements and coronary artery calcium in asymptomatic subjects (from the Early Identification of Subclinical Atherosclerosis by Noninvasive Imaging Research [EISNER] study)
Am J Cardiol, 2009. 104(9): p. 1245-50.
L. J. Shaw, et al.,

Clinical significance of borderline elevated troponin I levels across different assays in patients with suspected acute coronary syndrome
Am J Cardiol, 2009. 104(2): p. 164-8.
M. Zahid, et al.,

Association of neutrophil gelatinase-associated lipocalin with the severity of coronary artery disease
Am J Cardiol, 2009. 104(7): p. 917-20.
T. Zografos, et al.,

The impact of micro troponin leak on long-term outcomes following elective percutaneous coronary intervention
Catheter Cardiovasc Interv, 2009. 74(6): p. 819-22.
R. V. Milani, et al.,

Soluble CXCL16 predicts long-term mortality in acute coronary syndromes
Circulation, 2009. 119(25): p. 3181-8.
A. M. Jansson, et al.,

Multimarker approach to evaluate correlates of vascular stiffness: the Framingham Heart Study
Circulation, 2009. 119(1): p. 37-43.
W. Lieb, et al.,

Circulating endothelial cells: a new candidate biomarker of irreversible pulmonary hypertension secondary to congenital heart disease
Circulation, 2009. 119(3): p. 374-81.
D. M. Smadja, et al.,

Prognostic value of circulating chromogranin A levels in acute coronary syndromes
Eur Heart J, 2009. 30(1): p. 25-32.
A. M. Jansson, et al.,

High serum YKL-40 concentration is associated with cardiovascular and all-cause mortality in patients with stable coronary artery disease
Eur Heart J, 2009. 30(9): p. 1066-72.
J. Kastrup, et al.,

Cystatin C and cardiovascular mortality in patients with coronary artery disease and normal or mildly reduced kidney function: results from the AtheroGene study
Eur Heart J, 2009. 30(3): p. 314-20.
T. Keller, et al.,

Expression of stromal-cell-derived factor-1 on circulating platelets is increased in patients with acute coronary syndrome and correlates with the number of CD34+ progenitor cells
Eur Heart J, 2009. 30(5): p. 584-93.
K. Stellos, et al.,

Enhanced expression of haemoglobin scavenger receptor in accumulated macrophages of culprit lesions in acute coronary syndromes
Eur Heart J, 2009. 30(15): p. 1844-52.
K. Yunoki, et al.,

Limited utilities of N-terminal pro B-type natriuretic peptide and other newer risk markers compared with traditional risk factors for prediction of significant angiographic lesions in stable coronary artery disease
Heart, 2009. 95(4): p. 297-303.
A. Peer, et al.,

Inflammatory biomarkers and the prediction of coronary events among people at intermediate risk: the EPIC-Norfolk prospective population study
Heart, 2009. 95(20): p. 1682-7.
J. S. Rana, et al.,

Prognostic value of biomarkers during and after non-ST-segment elevation acute coronary syndrome
J Am Coll Cardiol, 2009. 54(4): p. 357-64.
K. M. Eggers, et al.,

Relationship of oxidized phospholipids and biomarkers of oxidized low-density lipoprotein with cardiovascular risk factors, inflammatory biomarkers, and effect of statin therapy in patients with acute coronary syndromes: Results from the MIRACL (Myocardial Ischemia Reduction With Aggressive Cholesterol Lowering) trial
J Am Coll Cardiol, 2009. 53(23): p. 2186-96.
A. E. Fraley, et al.,

Normal plasma levels of cardiac troponin I measured by the high-sensitivity cardiac troponin I access prototype assay and the impact on the diagnosis of myocardial ischemia
J Am Coll Cardiol, 2009. 54(13): p. 1165-72.
P. Venge, et al.,

Task force: nontraditional markers add little to heart risk assessment
JAMA, 2009. 302(20): p. 2192-3.
M. Mitka,

A sensitive cardiac troponin T assay in stable coronary artery disease
N Engl J Med, 2009. 361(26): p. 2538-47.
T. Omland, et al.,